Delivery Order SPE2DB22D1106-SPE2DB25FEQZ2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,808.10 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 ml) auto-injectors. This firm fixed-price, competitively awarded contract was issued on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,734.47 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Gvoke HypoPen auto-injectors (1 mg/0.2 ml, 2-pack). The contract, which represents a non-competitive delivery order under an existing indefinite delivery vehicle, will be fulfilled from the vendor's Conshohocken, Pennsylvania location with a completion date of September 10, 2025. This award is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,981.46 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Gvoke HypoPen 2-pack (1 mg/0.2 mL) auto-injectors. The contract, which is not set aside and was competitively awarded, specifies a firm fixed price structure with an ultimate completion date of June 2, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypopenTM auto-injector units (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $19,036.29. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contract specifies performance at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,684.93 to AmerisourceBergen Drug Corp for the supply of GVOKE HypoPin 2-pack auto-injectors (0.5mg/0.1ml) with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The GVOKE HypoPin is a glucagon emergency injection system used to treat severe hypoglycemia in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of GVOKE HypoGel auto-injectors (2-pack, 1 mg/0.2 ml dosage) with a ceiling value of $1,018.78. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order valued at $2,540.58 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoKit auto-injectors (2-pack, 1 mg/0.2 ml). This firm fixed-price delivery order, awarded on August 26, 2025, with completion targeted for August 27, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded. AmerisourceBergen, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a $21,248.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GVOKE HypoGen 2-pack auto-injectors (1 mg/0.2 ml), with an ultimate completion date of September 5, 2025. This non-set-aside competitive award leverages AmerisourceBergen's comprehensive indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $16,139.59. This is a firm fixed price delivery order with an ultimate completion date of April 25, 2025, to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this competitive award. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQZ2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,752.59 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of GVOKE HypopenTM auto-injector kits (2-pack, 1 mg/0.2 mL). This firm fixed-price delivery order, with an ultimate completion date of June 2, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company holds substantial delivery order authority under its prime IDC with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. GVOKE HypopenTM is a glucagon emergency injection system used to treat severe hypoglycemia, representing the specialized medical commodities that characterize AmerisourceBergen's federal contract portfolio. The DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen among key suppliers for ongoing federal pharmaceutical distribution needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.8k | 5/30/25 |